HematologieOnkologie

HematologieOnkologie is a medical specialty that combines hematology and oncology to diagnose, treat and monitor diseases of the blood, bone marrow and the body’s malignant conditions. The field encompasses benign hematologic disorders as well as hematologic malignancies such as leukemia, lymphoma and myeloma, and also addresses solid tumors within oncologic care. It also deals with related conditions like anemia, coagulation disorders and thrombosis, often in collaboration with other medical disciplines.

Diagnostics in HematologieOnkologie rely on a comprehensive evaluation that includes patient history and physical examination, laboratory tests (such as complete blood count and chemistry panels), coagulation studies, bone marrow examination, flow cytometry, cytogenetics and molecular testing, as well as imaging techniques like CT, MRI or PET-CT to determine extent and stage of disease and to guide therapy.

Treatments span systemic and local approaches. Systemic therapies include chemotherapy, targeted therapies, immunotherapies (including checkpoint inhibitors and CAR-T cell therapy) and hormonal therapies, as well as hematopoietic stem cell transplantation. Local treatments may involve radiotherapy. Supportive care is integral and includes transfusions, growth factors, antimicrobial prophylaxis, symptom control and palliative care. Goals of treatment range from curative intent to disease control and quality of life, tailored to disease type and patient status.

Care delivery is typically multidisciplinary, with teams in hospitals and specialized centers, frequent collaboration with surgery, radiation therapy, pathology, radiology and palliative care, and participation in clinical trials. Training for HematologieOnkologie involves dedicated residencies and fellowships, and the field maintains a strong emphasis on research and evidence-based practice.